Stay updated on Elranatamab Study in Relapsed/Refractory Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Elranatamab Study in Relapsed/Refractory Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Elranatamab Study in Relapsed/Refractory Multiple Myeloma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The record history now includes a new revision entry v3.4.3 and removes the previous revision v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T14:46:33.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    The study record now shows a Completed status with updated Study Status and Recruitment Status, and new References and Contacts/Locations sections have been added. The previous government-funding operating status notice has been removed.
    Difference
    1.0%
    Check dated 2026-02-11T02:13:29.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added a site-wide funding-status notice and updated the revision to v3.4.1 (replacing v3.4.0).
    Difference
    0.5%
    Check dated 2026-02-03T22:53:40.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The history page now displays a glossary, uses green/red highlights to show additions and deletions, and updates the revision label to v3.4.0 (replacing v3.3.4), with minor textual tweaks like capitalization of 'FEAR Act Data'.
    Difference
    0.6%
    Check dated 2026-01-27T20:59:22.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    Footer metadata updated with Revision: v3.3.3 and removal of HHS Vulnerability Disclosure and Revision: v3.3.2.
    Difference
    0.1%
    Check dated 2025-12-23T00:33:40.000Z thumbnail image
  8. Check
    106 days ago
    Change Detected
    Summary
    Revision updated from v3.3.1 to v3.3.2; no changes to study content or page functionality are visible. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T11:55:01.000Z thumbnail image

Stay in the know with updates to Elranatamab Study in Relapsed/Refractory Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Elranatamab Study in Relapsed/Refractory Multiple Myeloma Clinical Trial page.